Skip to main content
Log in

Serum S100B but not NSE Levels are Increased in Morbidly Obese Individuals Affected by Obstructive Sleep Apnea–Hypopnea Syndrome

  • Research Article
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Obstructive sleep apnea–hypopnea syndrome (OSAHS) is considered a comorbidity associated with morbid obesity, mainly because of the large neck circumference. Depending on its severity, OSAHS can interfere in many homeostasis systems, for example, the central nervous system (CNS). Neuron-specific enolase (NSE) and S100B protein derived from astrocytes are considered sensitive biochemical markers of cerebral injury. We evaluated serum S100B and NSE levels in this study with the aim of detecting possible cerebral injury as a consequence of OSAHS.

Methods

This was a transverse study with data from 25 morbidly obese patients with OSAHS. Blood samples were collected before and after polysomnography (PSG) to determine S100B and NSE protein levels. We also analyzed data evaluating depression and excessive daytime sleepiness.

Results

S100B levels were higher after [0.029 (0.010–0.199) mg/l] compared to before [0.010 (0.010–0.025) mg/l] on PSG (P = 0.002). S100B levels were expressed as means and IQ25–IQ75. NSE levels did not show significant differences before and after PSG.

Conclusion

Our study shows a significant increase in S100B level after PSG compared to before. This suggests that there is a CNS astrocyte reaction because of possible cerebral hypoxemia in morbidly obese patients with OSAHS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

OSAHS:

obstructive sleep apnea–hypopnea syndrome

CNS:

central nervous system

S100B:

a protein derived from astrocyte activity

NSE:

neuron-specific enolase (a glycolytic pathway enzyme from CNS)

PSG:

polysomnography

AHI:

apnea–hypopnea index

EDS:

excessive daytime sleepiness

References

  1. Fritscher LG, Mottin CC, Canani S, Chatkin JM. Obesity and obstructive sleep apnea–hypopnea syndrome: the impact of bariatric surgery. Obes Surg. 2007;17:95–9.

    Article  PubMed  Google Scholar 

  2. Peiser J, Lavie, P, Ovnat A, Charuzi I. Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery. Ann Surg. 1984;100:112–15.

    Google Scholar 

  3. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005;142:187–97.

    PubMed  Google Scholar 

  4. Naegele B, Thouvard V, Pepin JL, Levy P, Bonnet C, et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep. 1995;18:43–52.

    PubMed  CAS  Google Scholar 

  5. Macey PM, Henderson LA, Macey KE, Alger JR, Frysinger RC, et al. Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;166:1382–7.

    Article  PubMed  Google Scholar 

  6. Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, et al. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med. 2003;4:451–4.

    Article  PubMed  Google Scholar 

  7. Braga CW, et al. S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Med. 2006;12:1–5.

    Google Scholar 

  8. Jordan W, Hagedohm J, Wiltfang J, et al. Biochemical markers of cerebrovascular injury in sleep apnoea syndrome. Eur Respir J. 2002;20:158–64.

    Article  PubMed  CAS  Google Scholar 

  9. Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci. 2003;21:97–108.

    PubMed  Google Scholar 

  10. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60:540–51.

    Article  PubMed  CAS  Google Scholar 

  11. Kayser E, Kaiser R, Kuzmits P, et al. Clinical biochemistry of neuron specific enolase. Clin Chim Acta. 1989;183:13–32.

    Article  Google Scholar 

  12. Busnello JV. Acute and chronic electroconvulsive shock in rats: effects on peripheral markers of neuronal injury and glial activity. Life Sci. 2006;78:3013–17.

    Article  PubMed  CAS  Google Scholar 

  13. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.

    PubMed  CAS  Google Scholar 

  14. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.

    PubMed  CAS  Google Scholar 

  15. Rechtschaffen A, Kales AA. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Washington, DC: Public Health Service; 1968.

    Google Scholar 

  16. Guardiano SA, Scott JA, Ware C, Schechner SA. The long-term results of gastric bypass on indexes of sleep apnea. Chest. 2003;124:1615–19.

    Article  PubMed  Google Scholar 

  17. Rasheid S, Banasiak M, Gallagher SF, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obesity Surgery. 2004;13:58–61.

    Article  Google Scholar 

  18. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  PubMed  CAS  Google Scholar 

  19. Mazzini G, Schaf D, Oliveira AR, Goncalves CA, Souza DO, Portela LV. The ischemic rat heart releases S100B. Life Sci. 2005;77:882–89.

    Article  PubMed  CAS  Google Scholar 

  20. Willoughby KA, Kleindienst A, Müller C, Chen T, Muir JK, Ellis EF. S100B protein is released by in vitro trauma and reduces delayed neuronal injury. J Neurochem. 2004;91:1284–91.

    Article  PubMed  CAS  Google Scholar 

  21. Rothermundt M, Peters M, Prehn J, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Techn. 2004;60:614–32.

    Article  CAS  Google Scholar 

  22. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 2000;31:2670–7.

    PubMed  CAS  Google Scholar 

  23. Gale SD, Hopkins RO. Effects of hypoxia on the brain: neuroimaging and neuropsychological findings following carbon monoxide poisoning and obstructive sleep apnea. J Int Neurops Soc. 2004;10:60–71.

    Google Scholar 

  24. Halbower AC, Degaonkar M, Barker PB, Earley CJ, Marcus CL, Smith PL, et al. Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. Plos Med. 2006;3:301.

    Article  Google Scholar 

  25. Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, et al. Changes in brain morphology associated with obstructive sleep apnea. Sleep Med. 2003;4:451–4.

    Article  PubMed  Google Scholar 

  26. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001;18:491–8.

    Article  PubMed  CAS  Google Scholar 

  27. Hu J, Ferreira A, Van Eldik LJ. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem. 1997;69:2294–301.

    Article  PubMed  CAS  Google Scholar 

  28. Tramontina F, Conte S, Gonçalves D, Gottfried C, Portela LV, Vinade L, et al. Developmental changes in S100B content in brain tissue, cerebrospinal fluid, and astrocyte cultures of rats. Cell Mol Neurobiol. 2002;22:373–8.

    Article  PubMed  CAS  Google Scholar 

  29. Tramontina F, Tramontina AC, Souza DF, Leite MC, Gottfried C, Souza DO, et al. Glutamate uptake is stimulated by extracellular S100B in hippocampal astrocytes. Cell Mol Neurobiol. 2006;26:81–6.

    PubMed  Google Scholar 

  30. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, et al. S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol. 2003;13:235–9.

    Article  PubMed  CAS  Google Scholar 

  31. Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology. 2005;178:161–6.

    Article  PubMed  CAS  Google Scholar 

  32. Sriram K, Benkovic SA, Miller DB, O’Callaghan JP. Obesity exacerbates chemically induced neurodegeneration. Neuroscience. 2002;115:1335–46.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Special thanks for Dr Claudio Corá Mottin; Dr Diogo Onofre Souza; Dr Luiz Valmor Portela and Dr Renato Dutra Dias; for always stimulating the integration between Clinical and Basic Sciences Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leandro Giacometti da Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

da Silva, L.G., Mottin, C.C., Souza, D.O. et al. Serum S100B but not NSE Levels are Increased in Morbidly Obese Individuals Affected by Obstructive Sleep Apnea–Hypopnea Syndrome. OBES SURG 18, 993–999 (2008). https://doi.org/10.1007/s11695-007-9386-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-007-9386-6

Keywords

Navigation